logo
  

Ultragenyx Pharmaceutical Inc Q3 Profit beats estimates

Below are the earnings highlights for Ultragenyx Pharmaceutical Inc (RARE):

-Earnings: $72.9 in Q3 vs. $68.8 in the same period last year.
-EPS: $1.08 in Q3 vs. $1.13 in the same period last year.
-Analysts projected -$1.41 per share
-Revenue: $81.6 million in Q3 vs. $81.4 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

RELATED NEWS
Follow RTT